FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip

清脆的 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 突变 2019年冠状病毒病(COVID-19) 点突变 生物 病毒 病毒载量 病毒学 大流行 2019-20冠状病毒爆发 计算生物学 冠状病毒 遗传学 分子诊断学 基因组 Cas9
作者
Manoj Kumar,Sneha Gulati,Asgar Hussain Ansari,Rhythm Phutela,Sundaram Acharya,Mohd Azhar,Jayaram Murthy,Poorti Kathpalia,Akshay Kanakan,Ranjeet Maurya,Janani Srinivasa Vasudevan,Aparna S,Rajesh Pandey,Souvik Maiti,Debojyoti Chakraborty
出处
期刊:eLife [eLife Sciences Publications Ltd]
卷期号:10 被引量:18
标识
DOI:10.7554/elife.67130
摘要

The COVID-19 pandemic originating in the Wuhan province of China in late 2019 has impacted global health, causing increased mortality among elderly patients and individuals with comorbid conditions. During the passage of the virus through affected populations, it has undergone mutations, some of which have recently been linked with increased viral load and prognostic complexities. Several of these variants are point mutations that are difficult to diagnose using the gold standard quantitative real-time PCR (qRT-PCR) method and necessitates widespread sequencing which is expensive, has long turn-around times, and requires high viral load for calling mutations accurately. Here, we repurpose the high specificity of Francisella novicida Cas9 (FnCas9) to identify mismatches in the target for developing a lateral flow assay that can be successfully adapted for the simultaneous detection of SARS-CoV-2 infection as well as for detecting point mutations in the sequence of the virus obtained from patient samples. We report the detection of the S gene mutation N501Y (present across multiple variant lineages of SARS-CoV-2) within an hour using lateral flow paper strip chemistry. The results were corroborated using deep sequencing on multiple wild-type (n = 37) and mutant (n = 22) virus infected patient samples with a sensitivity of 87% and specificity of 97%. The design principle can be rapidly adapted for other mutations (as shown also for E484K and T716I) highlighting the advantages of quick optimization and roll-out of CRISPR diagnostics (CRISPRDx) for disease surveillance even beyond COVID-19. This study was funded by Council for Scientific and Industrial Research, India.SARS-CoV-2, the virus responsible for COVID-19, has a genome made of RNA (a nucleic acid similar to DNA) that can mutate, potentially making the disease more transmissible, and more lethal. Most countries have monitored the rise of mutated strains using a technique called next generation sequencing (NGS), which is time-consuming, expensive and requires skilled personnel. Sometimes the mutations to the virus are so small that they can only be detected using NGS. Finding cheaper, simpler and faster SARS-CoV-2 tests that can reliably detect mutated forms of the virus is crucial for public health authorities to monitor and manage the spread of the virus. Lateral flow tests (the same technology used in many pregnancy tests) are typically cheap, fast and simple to use. Typically, lateral flow assay strips have a band of immobilised antibodies that bind to a specific protein (or antigen). If a sample contains antigen molecules, these will bind to the immobilised antibodies, causing a chemical reaction that changes the colour of the strip and giving a positive result. However, lateral flow tests that use antibodies cannot easily detect nucleic acids, such as DNA or RNA, let alone mutations in them. To overcome this limitation, lateral flow assays can be used to detect a protein called Cas9, which, in turn, is able to bind to nucleic acids with specific sequences. Small changes in the target sequence change how well Cas9 binds to it, meaning that, in theory, this approach could be used to detect small mutations in the SARS-CoV-2 virus. Kumar et al. made a lateral flow test that could detect a Cas9 protein that binds to a nucleic acid sequence found in a specific mutant strain of SARS-CoV-2. This Cas9 was highly sensitive to changes in its target sequence, so a small mutation in the target nucleic acid led to the protein binding less strongly, and the signal from the lateral flow test being lost. This meant that the lateral flow test designed by Kumar et al. could detect mutations in the SARS-CoV-2 virus at a fraction of the price of NGS approaches if used only for diagnosis. The lateral flow test was capable of detecting mutant viruses in patient samples too, generating a colour signal within an hour of a positive sample being run through the assay. The test developed by Kumar et al. could offer public health authorities a quick and cheap method to monitor the spread of mutant SARS-CoV-2 strains; as well as a way to determine vaccine efficacy against new strains.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_VZG7GZ的应助被NJ采纳,获得10
刚刚
传奇3的应助被坚强白昼采纳,获得10
刚刚
田様的应助被LEON采纳,获得10
1秒前
1秒前
2秒前
2秒前
2秒前
2秒前
缥缈月光发布了新的文献求助10
3秒前
小羽完成签到,获得积分10
3秒前
WW完成签到,获得积分10
4秒前
4秒前
大气的fgyyhjj完成签到,获得积分10
5秒前
5秒前
Hello的应助被怕孤单的德天采纳,获得10
5秒前
谦让钥匙完成签到,获得积分10
5秒前
ami发布了新的文献求助10
5秒前
翟思宇发布了新的文献求助10
5秒前
6秒前
6秒前
何浏亮发布了新的文献求助10
6秒前
7秒前
DW的应助被小马采纳,获得10
9秒前
闲云野鹤完成签到,获得积分10
9秒前
彬彬完成签到,获得积分10
10秒前
谦让钥匙发布了新的文献求助10
10秒前
吗喽发布了新的文献求助10
10秒前
沉睡千年的蛆完成签到,获得积分10
11秒前
典雅秋白完成签到,获得积分10
11秒前
zyy发布了新的文献求助30
11秒前
温骐华完成签到 ,获得积分10
12秒前
缥缈月光完成签到,获得积分10
13秒前
共享精神的应助被敖烈采纳,获得10
13秒前
moose完成签到 ,获得积分10
13秒前
欢喜的乐安完成签到,获得积分10
13秒前
HaoruMeng发布了新的文献求助20
13秒前
14秒前
15秒前
寂寞的飞珍完成签到,获得积分10
15秒前
玛卡巴卡发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181940
求助须知:如何正确求助?哪些是违规求助? 9571697
关于积分的说明 21819181
捐赠科研通 7778330
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557767
邀请新用户注册赠送积分活动 2479621